INTRODUCTION
Central sensitization represents a sustained hypersensitive state of dorsal horn nociceptive neurons that can be evoked by peripheral inflammation or injury to nerves and tissues. Although NMDA and non-NMDA receptors are thought to be fundamental mechanisms underlying central sensitization (Ren and Dubner 1999; South et al., 2003; Woolf and Thompson 1991) The role of P2X receptors at peripheral sites has been extensively studied (for review, see Chizh and Illes 2000; Dunn et al. 2001; Hamilton and McMahon 2000; Jacobson et al. 2002; North 2003) . There has also been some limited identification of their role at central sites involved in nociceptive transmission and spinal dorsal horn sensitization, although some inconsistencies exist (for review, see Gu 2003; Salter 2004; Salter and Sollevi 2001) . While neurons cannot be functionally identified in in vitro preparations, in vitro studies have reported that neuronal excitatory postsynaptic currents in both superficial and deep spinal dorsal horn are modulated by local application of ATP or P2X receptor agonists and antagonists (Li et al. 1998; Nakatsuka et al., 2002 Nakatsuka et al., , 2003 Nakatsuka and Gu 2001) , and it has been proposed that ATP acts through presynaptic mechanisms to increase the release of glutamate and neuropeptides from the primary afferents (Gu 2003; Gu and MacDermott 1997; MacDermott et al. 1999 ). Earlier electrophysiological in vivo studies in the spinal dorsal horn had shown that some wide dynamic range (WDR) neurons as well as most low-threshold mechanoreceptive neurons can be excited by local ATP application (Fyffe and Perl 1984; Salter and Henry 1985;  for review see Salter et al. 1993 ). More recent studies have reported that intrathecal (i.t.) application of the selective P2X 1 receptor agonist β,γ-methylene ATP (β,γ-meATP), but not the selective P2X 1 , P2X 3 and P2X 2/3 receptor agonist α,β-methylene ATP (α,β-meATP), produces facilitation of C fiber-evoked responses of WDR neurons in the spinal dorsal horn in normal rats, whereas i.t. application of the wide spectrum P2X receptor antagonist pyridoxal-phosphate-6-azophenyl-2, 4-disulphonic acid tetra-sodium (PPADS) can attenuate these responses after carrageenan-induced inflammation . Behavioral studies in rodents however have reported that i.t. α,β-meATP, but not β,γ-meATP, elicits thermal hyperalgesia which can be prevented by i.t. pretreatment with the selective P2X 1 , P2X 3 and P2X 2/3 receptor antagonist, 2'-(or 3'-)O-trinitrophenyl-ATP (TNP-ATP) or PPADS, while i.t. TNP-ATP or PPADS or another non-selective antagonist (suramin) can attenuate nociceptive behavior associated with formalin-induced inflammation (Driessen et al. 1994; Tsuda et al. 1999a,b) . Other studies have reported that behavioral responses to noxious mechanical and thermal stimuli are unaltered in P2X 3 -knockout animals, whereas formalininduced nociceptive behavior is attenuated, suggesting that P2X 3 receptors are involved in certain types of inflammatory-related pain but not in acute nociceptive processing (Cockayne et al. 2000; Souslova et al., 2000) . These various findings collectively suggest that P2X receptors are important in nociceptive behavior and that P2X 3 receptors in particular may be involved in some inflammatory pain conditions, although there is some disagreement on the involvement of P2X 3 receptors in acute nociceptive processing in the spinal cord.
In the trigeminal system, we have also recently demonstrated that NMDA receptor mechanisms are involved in the initiation of central sensitization produced by application of the small-fiber excitant and inflammatory irritant mustard oil (MO) to the tooth pulp in brainstem nociceptive neurons of the trigeminal subnucleus caudalis (Vc) and the more rostral subnucleus oralis (Vo) (Chiang et al. 1998 (Chiang et al. , 2003a Park et al. 2001) . Furthermore, the central sensitization in Vo could be blocked by i.t. application to the Vc of TNP-ATP or the synaptic transmission blocker CoCl 2 and mimicked by i.t. application of α,β-meATP to the Vc (Chiang et al. 2002; Hu et al. 2002) , suggesting that P2X receptor mechanisms within Vc are involved in the development of central sensitization in Vo through ascending connections that have been documented from Vc to Vo (e.g., Greenwood and Sessle 1976; Jacquin et al. 1990; Young and King 1972) . So far, there has been no in vivo studies specifically to examine if P2X agonists and antagonists can modulate central sensitization of functionally identified nociceptive neurons in Vc itself. Therefore, the aims of the present study were to test (i) whether i.t. continuous superfusion over Vc of P2X receptor antagonists, TNP-ATP or PPADS, can attenuate the MO-induced central sensitization in Vc itself, and (ii) whether similar i.t. superfusion of apyrase, an ATP degrading enzyme (Zimmermann 2000) , can also attenuate this MO-induced central sensitization in Vc.
Some data have been briefly presented in abstract form (Chiang et al. 2003b , Zhang et al. 2004 ).
METHODS

Animal preparation
The experiments were performed in 34 anesthetized rats. The methods used for animal preparation, stimulation, and neuronal recording and classification were similar to those described previously in detail (Chiang et al. 1998; Hu et al. 2002) and so will only be briefly outlined here. Male Sprague-Dawley adult rats (300-380 g) were anesthetized by single i.p.
injection of a mixture of α-chloralose (50 mg/kg) and urethane (1 g/kg). Then a tracheal cannula was inserted and the left external jugular vein was cannulated. To expose the pulp of the right maxillary first molar, an occlusal cavity was prepared with a dental drill (Rotex TM 780) and immediately filled with a small piece of cotton pellet soaked with normal saline. After the rat was placed in a stereotaxic apparatus, the caudal medulla was surgically exposed and the overlying dura and subarachnoid membrane were removed. Just before the recording session, a supplemental dose of urethane (200-300 mg/kg, i.v.) was administered and the rat was then immobilized with i.v. pancuronium bromide (initial dose, 0.3 ml of 1 mg/ml solution, followed by a continuous i.v. infusion of a mixture of 70% urethane solution [0.2 g/ml] and 30 % pancuronium solution [1 mg/ml] at a rate of 0.4-0.5 ml/h) and artificially ventilated throughout the whole experimental period. A deep level of anesthesia was confirmed periodically by the lack of spontaneous movements and responses to pinching the paw when pancuronium-induced muscle paralysis was allowed to wear off. Heart rate, percentage expired CO 2 , and rectal temperature were constantly monitored and maintained at physiological levels of 333-430 beats/min, 3.5-4.2 %, and 37-37.5 °C, respectively. All surgeries and procedures were approved by the University of Toronto Animal Care Committee in accordance with the regulations of the Ontario Animal Research Act (Canada).
Recording and stimulation procedures
Single neuronal activity was recorded extracellularly by means of an epoxy resin-coated tungsten microelectrode. As the microelectrode was advanced with a rostral inclination of 23° into the right caudal medulla, 1.4-2.0 mm lateral to the midline and 1.5-2.0 mm behind the obex, natural stimuli (see below) were applied to the orofacial tissues to search for Vc nociceptive neurons receiving an orofacial sensory input. Neuronal activity was amplified, displayed on oscilloscopes and also led to a window discriminator connected to an A/D converter (Cambridge Electronic Design, CED 1401 plus, UK) and a personal computer. Data were analyzed off-line with Spike 2 software (Cambridge Electronic Design, UK).
A wide range of mechanical (brush, pressure and pinch), and noxious thermal (radiant heat, 51-53 °C) stimuli was applied to the orofacial region to classify each neuron as low-threshold mechanoreceptive (LTM), wide dynamic range (WDR) or nociceptive-specific (NS) (Chiang et al. 1998 (Chiang et al. , 2002 . Consistent with our earlier findings (Chiang et al. 1994 (Chiang et al. , 1998 , we observed that a majority of neurons in laminae I-IV respond to tactile alone (LTM) or both tactile and pinch stimuli (WDR), while most neurons (NS neurons) in lamina V and adjacent reticular formation responded only to firm pressure or pinch. Only NS neurons in the deep laminae of Vc were tested with the purinergic agents (see below).
The level of spontaneous activity of a NS neuron was determined over an initial 1 min recording period. As mentioned in our previous studies (Chiang et al. 1998 (Chiang et al. , 2002 Hu et al. 2002; Park et al. 2001) , the cutaneous perioral facial mechanoreceptive receptive field (RF) of each NS neuron was determined through the use of a blunt probe and a pair of non-serrated forceps.
A burst response consisting of at least 2 spikes during each stimulus trial was accepted as the criterion for the RF boundary of the neuron tested. Noxious stimulation was used sparingly so as to avoid damage to the skin and peripheral sensitization. A deep nociceptive input was considered to occur only if application of a blunt probe to the skin overlying muscle or bone evoked a neuronal response at a mechanical threshold above 5 g, but no response could be evoked by the wide range of mechanical pinch or thermal stimuli applied to the skin itself (Chiang et al. 1994; Yu et al. 1993) . The activation threshold to a mechanical stimulus applied to the orofacial RF was assessed by a pair of force-monitoring forceps (with an attached strain gauge that monitored force levels up to 600 g/mm 2 ) or an electronic von Frey monofilament.
The gradual increase in the mechanical force and the responses of the tested neuron were monitored and recorded simultaneously by the use of the Spike2 program (CED 1401 plus, UK).
The NS neuronal responses to graded pressure by means of electronic von Frey monofilament applications or graded mechanical pinch stimuli with a force-monitoring forceps (25 g, 50 g, 75 g, 100 g, and even 200 g, applied in ascending order, each for 5 s at an interval of >45 s) applied to the neuronal orofacial RF were determined as previously described (Chiang et al. 1998 (Chiang et al. , 2002 Hu et al. 2002; Park et al. 2001 ). The pinch-or pressure-evoked responses of a given neuron
were assessed by summing the number of spikes evoked by each of these 4 graded stimuli during application of the stimulus.
Chemicals
The chemicals used included MO (allyl isothiocynate, 95%; Aldrich Chemical Co., U.S.A.); PPADS (10, 33, 100 µg/ml, equivalent to 17, 55, 167 µM, were used; Research Biochemicals
International, Natick, MA, U.S.A.); TNP-ATP (5 or 500 µg/ml, equivalent to 6.4 or 638 µM, 
Histological and statistical analyses:
Recording sites were marked by electrolytic lesions (anodal current of 8 µA for 13 s), and verified histologically (e.g. see The level of significance was set at P<0.05.
RESULTS
Forty-two functionally identified NS neurons responding to ipsilateral orofacial noxious stimulation were studied. Nearly all of the recording sites were in the deep laminae of Vc ( Fig. 1 ).
Spontaneous activity
In the Saline/MO group (n=6), only 1 neuron had baseline activity (0.07Hz), and continuous i.t.
superfusion of saline did not affect its firing; however, the subsequent MO application produced an immediate response (up to 25 Hz) followed by sustained high firing (around 4 Hz) lasting 25 min in that neuron, and also produced a transient response (0.02-0.04 Hz) in 2 other neurons.
In the TNP-ATP/MO (5 µg/ml; n=6), PPADS/MO (33 µg/ml, n=6) and Apyrase/MO (30 units/ml, n=6) groups, none of these NS neurons tested had baseline activity. Continuous i.t.
superfusion of these chemicals did not evoke any spontaneous activity. In the TNP-ATP/MO low dose group, MO application produced an immediate response (up to 18 Hz for 3 min)
followed by low level of firing (0.1-2.8 Hz) for 30 min in 1 neuron, and produced a transient response (0.02-15 Hz) in another 2 neurons. With the higher dose of TNP-ATP (500 µg/ml, i.t.),
5 of the 6 neurons tested had no baseline activity, and the subsequent MO application produced a short-lasting and weak response (<0.6 Hz) in 3 neurons and a sustained high firing rate (up to 18
Hz) in 1 neuron. In both the PPADS/MO and apyrase/MO groups, the subsequent MO application did not evoke any spontaneous activity in any of these neurons.
Orofacial RF size
All 6 NS neurons in the Saline/MO group had at baseline an ipsilateral pinch/pressure RF (mean ± S.E.M.: 2.0 ± 0.5 cm 2 ) that involved both maxillary and ophthalmic divisions (5 had a dumbbell-like shaped RF involving the periorbital region, nose and vibrissal pad; 1 neuron had a periorbital RF). MO application to the pulp produced a significant, long-lasting increase in RF size in all neurons tested: their RFs not only expanded 100-200% beyond the original RF, but also reached the perioral region and medial face. Compared to the baseline value, the mean RF size increased significantly throughout the 50-min observation period after MO application (P<0.001, RM ANOVA), with its peak at 18 min (P<0.05, Dunnett's test) as shown in Fig. 2 , and Table 1 . In addition, soon after MO application, a novel tactile RF appeared for 10-30 min in 3 of the 6 neurons.
The 6 NS neurons in the low dose (5 µg/ml) TNP-ATP/MO group had at baseline an ipsilateral RF with a mean size of 1.7 ± 0.4 cm 2 : the RF of these neurons involved both maxillary and ophthalmic divisions (3 had a dumbbell-shaped RF covering the periorbital region and vibrissal pad; other 3 had a RF covering the nose and/or vibrissal pad). As shown in Figs. 2 and Table 1, TNP-ATP continuous superfusion itself did not affect the neuronal RF size, but the subsequent MO application produced a small but significant increase in RF size of these neurons (P<0.01, RM ANOVA); however, no novel tactile RF appeared in any of these neurons. Even in the higher dose (500 µg/ml) TNP-ATP group, this MO-induced RF expansion still occurred (P<0.005, RM ANOVA), and was associated with a transient appearance of a novel tactile RF.
The 6 NS neurons tested in the PPADS/MO group had a mean baseline ipsilateral RF size of 1.2 ± 0.2 cm 2 : the RF of 5 neurons involved the maxillary division (the vibrissal pad in 3 and the perioral region in 2); the RF in the remaining 1 neuron included both maxillary and ophthalmic divisions. As shown in Fig. 2 and Table 1 , neither PPADS superfusion itself nor the subsequent MO application significantly affected RF sizes (P>0.3, RM ANOVA). Also, no novel tactile RF appeared in any of these neurons.
The 6 NS neurons tested in the Apyrase/MO group had a mean baseline RF size of 1.3 ± 0.3 cm 2 ; all their RFs involved the maxillary and/or ophthalmic divisions (the vibrissal pad and nose in 3, the periorbital region in 2, and the nose in 1). Apyrase superfusion itself did not affect RF size. Thirty min later, MO application did not produce any significant changes in RF size (P>0.3, RM ANOVA; Fig. 2 ).
The differences in RF size after MO application between the Saline/MO group and each of the TNP-ATP/MO, PPADS/MO, and Apyrase/MO groups were significant (P<0.001-0.006, Table 1 ).
Mechanical activation threshold
The 6 NS neurons tested in the Saline/MO group had at baseline a mean threshold of 100 ± 38 g, which was significantly decreased to 50% of control after MO application (P=0.002, RM ANOVA); the peak decrease occurred at 18 min (P<0.05, Dunnett's test) ( Fig. 3 and Table 1 ).
The 6 NS neurons tested in each of the low dose TNP-ATP/MO, high dose TNP-ATP, PPADS/MO, and Apyrase/MO groups had a mean baseline threshold of 85 ± 17 g, 94 ± 23 g, 93
± 17 g, and 76 ± 16 g, respectively. Chemical superfusion did not produce any significant changes in threshold values (P>0.3-0.9, RM ANOVA; Fig. 3 ). The subsequent MO application produced a significant decrease in threshold in the high dose TNP-ATP group (P<0.05, ANOVA), but not in the other 3 groups.
The differences in activation threshold after MO application between the Saline/MO group and the PPADS/MO or Apyrase/MO or high dose TNP-ATP group were significant (P<0.05), while those between the Saline/MO group and the low dose TNP-ATP/MO group were not significant (P>0.09; Table 1 ).
Responses to graded pinch/pressure stimuli
In the Saline/MO group, the mean baseline response to graded pinch/pressure stimuli was 52 ± 5
spikes. The response in 5 of 6 NS neurons tested was increased after MO application. The mean response increased significantly to a twofold peak at 18 min and then slowly declined but had not reached baseline levels by 50 min (P=0.02, RM ANOVA) (Fig. 4 and Table 1 ).
In the low dose TNP-ATP/MO group, the mean baseline response was 81 ± 30 spikes, and 2 of the 6 NS neurons tested showed increases in responses after TNP-ATP continuous superfusion.
The subsequent MO application to the pulp also produced marked increases in responses (190-880% of control) in only 3 of the 6 neurons, and the mean response was not significantly different from baseline (P>0.3, RM ANOVA on ranks; Fig. 4) . Similarly, in the high dose TNP-ATP group which had a mean baseline response of 66 ± 20 spikes, 4 of 6 NS neurons responded markedly to graded pinch stimuli after MO application, but again the mean response was not significantly different from baseline (P>0.4, RM ANOVA).
The 6 NS neurons tested in each of the PPADS/MO and Apyrase/MO groups had a mean baseline response of 61 ± 10 and 162 ± 28 spikes, respectively. Neither PPADS nor apyrase superfusion nor the subsequent MO application produced significant changes in the neuronal responses to noxious graded mechanical stimuli (P>0.2-0.9, RM ANOVA on ranks; Fig. 4 ).
The differences in responses after MO application between these 4 chemical superfusion groups and the Saline/MO group were not significant (P>0.09, Table 1 ). Examples of NS neurons in the Saline/MO, low dose TNP-ATP/MO, PPADS/MO, and Apyrase/MO groups are illustrated in Fig. 5 .
Dose-response effects of PPADS
It is noteworthy that PPADS dose-dependently attenuated the MO-induced neuroplastic changes in activation threshold, RF size and responses to graded pinch/pressure stimuli of the neurons. As shown in Fig. 6 , the blocking effect was plotted against different doses of PPADS (10, 33, and 100 µg/ml, i.t.). The group receiving the 10 µg/ml dose showed marked blocking effects, and there were significant differences in all 3 measures of neuronal properties between either the 33 or 100 µg/ml dose group and the Saline/MO group (as a control) (P<0.02-0.001, ANOVA). Moreover, the maximal blocking effects produced by 33 µg/ml of PPADS were not further increased or decreased by the use of 100 µg/ml. In the spinal dorsal horn, the P2X subtypes 1, 2, 4-6 are expressed intrinsically and the P2X 3 subtype is exclusively expressed in the dorsal root and trigeminal ganglion cells and their central terminals (Vulchanova et al. 1998) . The P2X 2 , P2X 4 , and P2X 6 subtypes are the most abundant in the dorsal horn (in lamina II in particular), and P2X 1 and P2X 5 are localized predominantly in the central and ventral gray matter (Collo et al. 1996; Vulchanova et al. 1998 ). However, only P2X 4 and P2X 6 subtypes appear to be expressed in Vc (Collo et al. 1996) . While the effect of TNP-ATP on P2X 6 subtypes has not been tested to date, several recent in vitro studies have confirmed that the P2X [1] [2] [3] [4] subtypes are sensitive to TNP-ATP and only the P2X 4 subtype is relatively resistant to PPADS (Bo et al., 1995; Buell et al., 1996; Chizh and Illes 2000; Tsuda et al., 2003; Virginio et al., 1998 ; for reviews Our results showed that apyrase potently attenuates the MO-induced neuroplastic changes.
DISCUSSION
Although this could indicate that either P2X or P2Y 2 or both receptors may play a critical role in producing central sensitization (for review, see North and Barnard 1997), our findings with P2X receptor antagonists in the tooth pulp inflammatory pain model suggest that the P2X [1] [2] [3] 6 subtypes may be involved (for review, see Gu 2003; Kennedy et al. 2003) , whereas the P2X 4 subtype is likely not involved. Since the final end product of ATP degradation is adenosine, which is known as a potent inhibitor acting on purinergic A receptors (for review, see Salter et al. 1993; Salter and Sollevi 2001; Sawynok 1998) , the pharmacological action of apyrase may be dichotomized into two components: one is a direct degradation of endogenous ATP which may presynaptically interfere with the initiation of central sensitization, and the other is an inhibition produced by the end-product adenosine that also interferes with the development of central sensitization. Taken Note that after saline superfusion, MO application to the pulp (at 0 min) produced significant increases in pinch/pressure RF size throughout the 50 min observation period (P<0.001, RM ANOVA; *P<0.05, Dunnett's test), while after PPADS (33 µg/ml) and apyrase (30 U/ml) superfusion, MO application no longer produced increases in pinch RF size. However, after TNP-ATP (5 µg/ml) superfusion, MO application still produced significant increases in pinch RF size despite potently attenuating RF increases (P=0.006, RM ANOVA; *P<0.05, Dunnett's test).
There were significant differences between the 3 drug groups and saline group (all P<0.001, twoway RM ANOVA) and the values at every post-MO test time point (#P<0.05, Bonferroni t-test).
Each group consists of 6 NS neurons located in deep laminae of Vc. Arrows indicate the application time of drugs or saline. Note that apyrase superfusion started 30 min prior to MO application to the tooth pulp. Note that after saline superfusion, MO application to the pulp (at 0 min) produced significant increases in responses to graded mechanical stimuli throughout the 50 min observation period (P=0.05, RM ANOVA; *P<0.05, Dunnett's test), while after TNP-ATP (5 µg/ml), PPADS (33 µg/ml) and apyrase (30 U/ml) superfusion, MO application no longer produced significant increases in responses to graded mechanical stimuli. There were significant differences between PPADS/MO or Apyrase/MO groups and saline group (P<0.05-0.01, two-way RM ANOVA).
Each group consists of 6 NS neurons located in deep laminae of Vc. Arrows indicate the application time of drugs or saline. Note that in the PPADS/MO group, 3 different doses were applied: 10 µg/ml, n=3; 33 µg/ml, n=6; 100 µg/ml, n=4; in the Saline/MO group, n=6. There were significant differences in all 3 measures of neuronal properties between either the 33 or 100 µg/ml dose group and the 
TNP-ATP/MO experiments
Number of NS neurons 6 6 6 Baseline value 1.7 ± 0.4 85 ± 16.9 81.3 ± 30
Value 10' after TNP-ATP Value 48' after MO 1.9 ± 0.5 86.2 ± 13.4 62 ± 22.7
PPADS/MO experiments
Number of NS neurons 6 6 6 Baseline value 1.2 ± 0.2 92.5 ± 17.4 60.7 ± 9.9
Value 10' after PPADS All values are shown as mean ± S.E.; * = P<0.05 for comparison between the baseline value and values at the different time after drug or saline in each group (RM ANOVA followed by Dunnett's test); a = two-way RM ANOVA results for comparison of all time courses between Saline/MO and other drug/MO groups. 
